FITC anti-mouse/human CD11b Antibody

Pricing & Availability
Clone
M1/70 (See other available formats)
Regulatory Status
RUO
Other Names
αM integrin, Mac-1, Mo1, CR3, Ly-40, C3biR, ITGAM
Isotype
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
M1slash70_FITC_1_110210
C57BL/6 mouse bone marrow cells were stained with CD11b (clone M1/70) FITC (top) or rat IgG2b, κ FITC isotype control (bottom) (gated on total viable cells).
  • M1slash70_FITC_1_110210
    C57BL/6 mouse bone marrow cells were stained with CD11b (clone M1/70) FITC (top) or rat IgG2b, κ FITC isotype control (bottom) (gated on total viable cells).
  • M1slash70_FITC_2_110210
Compare all formats See FITC spectral data
Cat # Size Price Quantity Check Availability Save
101205 50 µg 38€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
101206 500 µg 106€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD11b is a 170 kD glycoprotein also known as αM integrin, Mac-1 α subunit, Mol, CR3, and Ly-40. CD11b is a member of the integrin family, primarily expressed on granulocytes, monocytes/macrophages, dendritic cells, NK cells, and subsets of T and B cells. CD11b non-covalently associates with CD18 (β2 integrin) to form Mac-1. Mac-1 plays an important role in cell-cell interaction by binding its ligands ICAM-1 (CD54), ICAM-2 (CD102), ICAM-4 (CD242), iC3b, and fibrinogen.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse, Human, Cynomolgus, Rhesus
Reported Reactivity
Chimpanzee, Baboon, Rabbit
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
C57BL/10 splenocytes
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with FITC under optimal conditions.
Concentration
0.5 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested

Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Application Notes

Clone M1/70 has been verified for immunocytochemistry (ICC) and frozen immunohistochemistry (IHC-F).

Additional reported applications (for relevant formats of this clone) include: immunoprecipitation1,4, in vitro blocking3,9,12, depletion2,8, immunofluorescence microscopy6,7,10, immunohistochemistry of acetone-fixed frozen sections5,11-13, and spatial biology (IBEX)35,36. For in vivo studies or highly sensitive assays, we recommend Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) (Cat. No. 101248).

Application References
  1. Springer T, et al. 1978. Eur. J. Immunol. 8:539. (IP)
  2. Ault K and Springer T. 1981. J. Immunol. 126:359. (Deplete)
  3. Springer TA, et al. 1982. Immunol. Rev. 68:171. (Block)
  4. Ho MK and Springer TA. 1983. J. Biol. Chem. 258:2766. (IP)
  5. Flotte TJ, et al. 1983. Am. J. Pathol. 111:112. (IHC)
  6. Noel GJ, et al. 1990. J. Clin. Invest. 85:208. (IF)
  7. Allen LA and Aderem A. 1996. J. Exp. Med. 184:627 (IF)
  8. D'Amico A and Wu L. 2003. J. Exp. Med. 198:293. (Deplete)
  9. Brickson SJ, et al. 2003. Appl Physiol. 95:969. (Block)
  10. Clatworthy MR and Smith KG. 2004. J. Exp. Med. 199:717. (IF)
  11. Hata H, et al. 2004. J. Clin. Invest. 114:582. (IHC)
  12. Zhang Y, et al. 2002. J. Immunol. 168:3088. (IHC)
  13. Iwasaki A and Kelsall BL. 2001. J. Immunol. 166:4884 (IHC, FC)
  14. Tailleux L. 2003. J. Exp. Med. 197:121. (Block, FC)
  15. Olver S, et al. 2006. Cancer Research 66:571. (FC)
  16. Tan SL, et al. 2006. J. Immunol. 176:2872. (FC) PubMed
  17. Ponomarev ED, et al. 2006. J. Immunol. 176:1402. (FC)
  18. Dzhagalov I, et al. 2007. Blood 109:1620. (FC)
  19. Fazilleau N, et al. 2007. Nature Immunol. 8:753.
  20. Rasmussen JW, et al. 2006. Infect. Immun.74:6590. PubMed
  21. Napimoga MH, et al. 2008. J. Immunol. 180:609. PubMed
  22. Elqaraz-Carmon V, et al. 2008. J. Lipid. Res. 49:1894. PubMed
  23. Kim DD, et al. 2008. Blood 112:1109. PubMed
  24. Guo Y, et al. 2008. Blood 112:480. PubMed
  25. Norian LA, et al. 2009. Cancer Res. 69:3086. (FC) PubMed
  26. Baumgartner CK, et al. 2010. J. Immunol. 184:573. PubMed
  27. Charles N, et al. 2010. Nat. Med. 16:701. (FC) PubMed
  28. Whiteland J, et al. 1995. J. Histochem. Cytochem. 43:313. (IHC)
  29. Weber GF, et al. 2014. J Exp Med. 211:1243. PubMed
  30. Ashok A, et al. 2015. Toxicol Sci. 143:64. PubMed
  31. Price PJ, et al. 2015. J Immunol. 194:1164. PubMed
  32. Doni A, et al. 2015. J Exp Med. 212:905. PubMed
  33. Ferreira R, et al. 2016. J Infect Dis. 213: 669 - 673. PubMed
  34. Peterson VM, et al. 2017. Nat. Biotechnol. 35:936. (PG)
  35. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  36. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Gupta P, Rajan M, Kulkarni S, et al. 2017. Int Immunopharmacol. 10.1016/j.intimp.2017.06.025. PubMed
  2. Haimon Z et al. 2018. Nature immunology. 19(6):636-644 . PubMed
  3. Bijland S, et al. 2019. F1000Res. 8:117. PubMed
  4. Furuhashi K, et al. 2017. Immunology. 151:227. PubMed
  5. Miyatake Y, et al. 2018. J Immunol. 201:3051. PubMed
  6. Wang X, et al. 2019. Cell Res. 29:787. PubMed
  7. Narusawa M, et al. 2014. Cancer Immunol Res. 2:568. PubMed
  8. Ostapoff K, et al. 2014. Cancer Res. 74:4966. PubMed
  9. Fan X, et al. 2015. Cancer Res. 75:86. PubMed
  10. Wang L, et al. 2020. Front Cell Dev Biol. 0.745138889. PubMed
  11. Moreno-García Á, et al. 2020. Biomolecules. 10:00. PubMed
  12. Xue F, et al. 2020. Int J Biol Sci. 2.105555556. PubMed
  13. Petrova T, et al. 2020. Sci Rep. 10:3479. PubMed
  14. Kiepura A, et al. 2021. Int J Mol Sci. 22:. PubMed
  15. Guo H, et al. 2020. Curr Protoc Immunol. 131:e107. PubMed
  16. Xiang G, et al. 2022. Cell Death Dis. 13:451. PubMed
  17. Schädlich IS, et al. 2022. iScience. 25:104470. PubMed
  18. Furrer R, et al. 2021. Sci Adv. 7:eabi4852. PubMed
  19. Li Z, et al. 2022. Nat Commun. 13:1845. PubMed
  20. Bruggemann TR, et al. 2022. iScience. 25:105185. PubMed
  21. Giorgetti E, et al. 2020. Cell Reports. 29(6):1539-1554.e7.. PubMed
  22. Viny AD, et al. 2019. Cell Stem Cell. 25:682. PubMed
  23. Fu R, et al. 2020. Sci Rep. 10:1455. PubMed
  24. Liu W, et al. 2020. Mol Ther Oncolytics. 17:350. PubMed
  25. Huang Z et al. 2017. Cell metabolism. 26(3):493-508 . PubMed
  26. Bo Yu et al. 2018. Cell stem cell. 23(2):193-209 . PubMed
  27. Shavit Stein E, et al. 2018. Neural Plast. 2018:7692182. PubMed
  28. Pathak JL, et al. 2021. Front Cell Dev Biol. 628139:9. PubMed
  29. McNamara HA, et al. 2020. Cell Host Microbe. 572:28. PubMed
  30. Kim JS, et al. 2020. Immunity. 54(1):176-190.e7. PubMed
  31. Rosenkranz SC, et al. 2021. eLife. 10:00. PubMed
  32. Han X, et al. 2017. Int J Mol Sci. 10.3390/ijms18050942. PubMed
  33. Belmonte L, et al. 2016. Sci Rep. 6:35813. PubMed
  34. Nocera D, et al. 2016. J Immunol. 196: 2860 - 2869. PubMed
  35. Jackson A, et al. 2014. J Leukoc Biol. 92:609. PubMed
  36. Tan L, et al. 2022. Biochem Biophys Rep. 32:101351. PubMed
  37. Schönberger K, et al. 2022. Cell Stem Cell. 29:131. PubMed
  38. Di Martile M, et al. 2020. J Immunother Cancer. 8:. PubMed
  39. Gan C, et al. 2022. Respir Res. 23:32. PubMed
  40. He J, et al. 2022. Front Immunol. 12:760138. PubMed
  41. Qi Z, et al. 2022. Nat Commun. 13:182. PubMed
  42. Okajima T, et al. 2021. Front Immunol. 12:738041. PubMed
  43. Zhang Y, et al. 2018. Sci Rep. 8:5994. PubMed
  44. Zhang YS, et al. 2018. Cancer Biol Ther. 19:735. PubMed
  45. Chou YJ, et al. 2020. Sci Rep. 10:8422. PubMed
  46. Wu G, et al. 2020. Front Oncol. 10:194. PubMed
  47. Lee H, et al. 2020. Cell Metabolism. 31(4):822-836. PubMed
  48. Lin R, et al. 2020. Sci Rep. 10:14397. PubMed
  49. Koning B, et al. 2006. Int Immunol. 1.403472222. PubMed
  50. Kapadia D, et al. 2011. PLoS One. 6:e19376. PubMed
  51. Paschall A, et al. 2015. J Immunol. 194: 2369-2379. PubMed
  52. Su N, Xiong Y 2016. Sci Rep. 6:22658. PubMed
  53. Tu S, et al. 2020. Cellular Signalling. 73:109695. PubMed
  54. Pandey S, et al. 2020. Cell Syst. 11:495. PubMed
  55. Tuominen S, et al. 2021. Eur J Nucl Med Mol Imaging. 48:1312. PubMed
  56. Li Y, et al. 2021. Basic Res Cardiol. 116:30. PubMed
  57. Poli V, et al. 2021. iScience. 24:103256. PubMed
  58. Xu ZH, et al. 2021. Mediators Inflamm. 2021:8856326. PubMed
  59. Choi YY, et al. 2021. Cell Death Dis. 12:826. PubMed
  60. Johnson KD, et al. 2022. Blood Adv. 6:1464. PubMed
  61. Zhu ZY, et al. 2022. Front Immunol. 12:781087. PubMed
  62. Chen L, et al. 2022. Mol Ther Oncolytics. 24:522. PubMed
  63. Liang S, et al. 2022. Acta Pharm Sin B. 12:2494. PubMed
  64. Almeida AS, et al. 2021. Bio Protoc. 11:e4012. PubMed
  65. Hu J, et al. 2021. Sci Adv. 7:. PubMed
  66. Chen S, et al. 2022. Cancer Discov. :. PubMed
  67. Patel T, et al. 2022. Aging Cell. 21:e13606. PubMed
  68. Yang W, et al. 2020. Nat Commun. 3.553472222. PubMed
  69. Zaytseva D, et al. 2018. Physiol Rep. 6:e13812. PubMed
  70. Tong X, et al. 2020. Front Pharmacol. 1.404166667. PubMed
  71. Shang W, et al. 2019. J Diabetes Res. 2019:5641271. PubMed
  72. Periasamy S, et al. 2017. Nat Commun. 8:15564. PubMed
  73. Lindborg JA et al. 2017. The Journal of Neuroscience. 37(43):10258-10277 . PubMed
  74. Klichinsky M, et al. 2020. Nat Biotechnol. 38:947. PubMed
  75. Stahnke S, et al. 2021. Current Biology. 31(10):2051-2064.e8. PubMed
  76. Zhang S, et al. 2021. Cell. 184(8):2151-2166.e16. PubMed
  77. Yousif AS, et al. 2020. Immunity. 54(2):235-246.e5. PubMed
  78. Mirshahi F, et al. 2022. Cell Rep. 38:110454. PubMed
  79. Duan M, et al. 2022. Cell Commun Signal. 20:60. PubMed
  80. Zhang Q, et al. 2021. Theranostics. 11:8301. PubMed
  81. Li B, et al. 2022. iScience. 25:103772. PubMed
  82. DeMarco JK, et al. 2021. Vaccines (Basel). 9:. PubMed
  83. Siew JJ, et al. 2019. Nat Commun. 10:3473. PubMed
  84. Verma M, et al. 2018. Brain Behav Immun. 69:223. PubMed
  85. Duarte N, et al. 2018. Hepatol Commun. 0.833333333. PubMed
  86. Di Gioia M, et al. 2020. Nat Immunol. 21:42. PubMed
  87. Pham THM, et al. 2020. Cell Host & Microbe. 27(1):54-67.e5.. PubMed
  88. Guan H, et al. 2012. PLoS One. 7:e35650. PubMed
  89. Caiado F, et al. 2013. Cancer Res. 73:4233. PubMed
  90. Lin T, et al. 2015. PLoS One. 10: e0138335. PubMed
  91. Esmaili S, et al. 2021. Cell Systems. 12(5):432-445.e7. PubMed
  92. Jeong D, et al. 2021. eLife. 0.416666666666667. PubMed
  93. Luff DH, et al. 2021. Front Immunol. 631271:12. PubMed
  94. Yang C, et al. 2020. J Control Release. 326:324. PubMed
  95. Inoue D, et al. 2021. Nat Genet. 53:707. PubMed
  96. Go DM, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:715. PubMed
  97. Tanner MA, et al. 2021. Am J Physiol Heart Circ Physiol. 321:H633. PubMed
  98. Kasper M, et al. 2021. Elife. 10:. PubMed
  99. Bae SH, et al. 2021. Theranostics. 11:2522. PubMed
  100. Helm M, et al. 2022. Life (Basel). 12:. PubMed
  101. Yang W, et al. 2020. Mucosal Immunol. 13:788. PubMed
  102. Peng L, et al. 2020. Transl Lung Cancer Res. 0.892361111. PubMed
  103. Privratsky JR, et al. 2018. Am J Physiol Renal Physiol. 315:F682. PubMed
  104. Luo W, et al. 2019. Mol Med Rep. 20:1007. PubMed
  105. Mayers S, et al. 2019. BMC Biotechnol. 19:21. PubMed
  106. Dey A et al. 2019. The EMBO journal. 38(7) pii: e100293. PubMed
  107. Best SA, et al. 2018. Cell Metab. 27:935. PubMed
  108. Ostendorf BN, et al. 2020. Nat Med. 26:1048. PubMed
  109. Yi M, et al. 2021. J Hematol Oncol. 14:27. PubMed
  110. Periasamy S, et al. 2011. J Leukoc Biol. 90:493. PubMed
  111. Kan C, et al. 2022. Bone Res. 10:62. PubMed
  112. Zhang J, et al. 2021. J Leukoc Biol. 110:485. PubMed
  113. Qiu F, et al. 2022. J Cancer. 13:2893. PubMed
  114. Zhang J, et al. 2022. Front Immunol. 13:931740. PubMed
  115. Hou H, et al. 2021. Front Cell Dev Biol. 9:737003. PubMed
  116. Antunes KH, et al. 2022. Front Immunol. 13:867022. PubMed
  117. Liang P, et al. 2022. Mol Biomed. 3:14. PubMed
  118. Wu Q, et al. 2022. Cell Mol Life Sci. 79:137. PubMed
  119. Li Y, et al. 2022. Clin Transl Immunology. 11:e1362. PubMed
  120. Tanaka Y, et al. 2021. Int J Mol Sci. 22:. PubMed
  121. Kunimoto H, et al. 2018. Cancer Cell. 33:44. PubMed
  122. Zong Z, et al. 2019. Front Immunol. 10:1643. PubMed
  123. Zhang D, et al. 2020. Signal Transduct Target Ther. 5:24. PubMed
  124. Qi X, et al. 2019. Nat Med. 25:1225. PubMed
  125. Marchingo JM, et al. 2020. eLife. 9:e53725.. PubMed
  126. Lee M, et al. 2014. PLoS One. 9:112666. PubMed
  127. Velázquez K, et al. 2016. Am J Physiol Gastrointest Liver Physiol. 311: G699 - G712. PubMed
  128. Chi Z, et al. 2020. Molecular Cell. 80(1):43-58.e7. PubMed
  129. Dang Y, et al. 2022. Cancer Cell Int. 22:88. PubMed
  130. Almeida AS, et al. 2021. Bio Protoc. 11:e4012. PubMed
  131. Yao L, et al. 2021. J Bone Miner Res. 36:1159. PubMed
  132. Shen Y, et al. 2022. CNS Neurosci Ther. 28:46. PubMed
  133. Rao X, et al. 2022. Cell Death Dis. 13:891. PubMed
  134. Geng T, et al. 2022. Methods Mol Biol. 2585:71. PubMed
  135. Maluski M, et al. 2019. J Clin Invest. 129:5108. PubMed
  136. Perez–Zsolt D, et al. 2019. Front Immunol. 0.989583333. PubMed
  137. Xiao P, et al. 2019. J Exp Med. 216:337. PubMed
  138. Deng Z, et al. 2017. Oncogene. 36:639. PubMed
  139. Varol D et al. 2017. Immunity. 46(6):1030-1044 . PubMed
  140. Ye Z, et al. 2019. Mediators Inflamm. 2019:8709583. PubMed
  141. Marks KE, et al. 2021. Cell Reports. 35(13):109303. PubMed
  142. Ohgomori T, et al. 2020. Neuropharmacology. 176:108227. PubMed
  143. Alshetaiwi H, et al. 2020. Sci Immunol. 5:00. PubMed
  144. Köchl R, et al. 2020. Elife. 9:00. PubMed
  145. Lin D, et al. 2015. Proc Natl Acad Sci U S A. 112: 11324-11329. PubMed
  146. Madan-Lala R, et al. 2014. J Immunol. 192:4263. PubMed
  147. Ippolito G, et al. 2014. Proc Natl Acad Sci U S A. 111:998. PubMed
  148. Yuan F, et al. 2022. Front Immunol. 13:798583. PubMed
  149. Forbester JL, et al. 2020. J Virol. 94:. PubMed
  150. Wu H, et al. 2022. Biomolecules. 12:. PubMed
  151. Zhang B, et al. 2021. Nat Biomed Eng. 5:1288. PubMed
  152. Gao H, et al. 2021. Cells. 10:. PubMed
  153. Saitoh BY, et al. 2021. Brain Behav Immun. 95:362. PubMed
  154. Knolle MD et al. 2018. Frontiers in immunology. 1.925 . PubMed
  155. Doonan J, et al. 2019. Nat Commun. 10:1554. PubMed
  156. Wang F, et al. 2018. Carcinogenesis. 39:889. PubMed
  157. Greenwald AC, et al. 2019. J Exp Med. 216:215. PubMed
  158. Codina A, et al. 2019. Cell Syst. 8:136. PubMed
  159. Srivastava S, et al. 2019. Cancer Cell. 35:489. PubMed
  160. Wang ECE, et al. 2019. Cell Stem Cell. 24:654. PubMed
  161. Schadt L, et al. 2020. Cell Reports. 29(5):1236-1248.e7.. PubMed
  162. Yee PP, et al. 2020. Nat Commun. 4.225. PubMed
  163. Tan A, et al. 2012. Mol Pharmacol. 9:2710. PubMed
  164. Cappello P, et al. 2013. Gastroenterology. 144:1098. PubMed
  165. Meraz I, et al. 2014. PLoS One. 9:94703. PubMed
  166. Aebischer D, et al. 2014. PLoS One. 9:99297. PubMed
  167. Lehmann M, et al. 2016. J Leukoc Biol. 99: 1057 - 1064. PubMed
  168. Lu X, et al. 2016. Nat Commun. 7: 12719. PubMed
  169. Koivisto CS, et al. 2020. Neoplasia. 1.252777778. PubMed
  170. He Y, et al. 2021. Cell Metabolism. 33(5):988-1000.e7. PubMed
  171. Okubo K, et al. 2021. Cell Reports. 35(7):109142. PubMed
  172. Derecka M, et al. 2020. Nat Immunol. 261:21. PubMed
  173. Zhang F, et al. 2020. EMBO Mol Med. e12034:12. PubMed
  174. Dong S, et al. 2021. Nature. 591:117. PubMed
  175. Dang Y, et al. 2021. J Cancer. 12:7158. PubMed
  176. Suryawanshi RK, et al. 2021. Nat Commun. 12:6020. PubMed
  177. Yadav P, et al. 2021. J Immunol. 206:2888. PubMed
  178. Friedman DJ, et al. 2021. Cancer Immunol Res. 9:952. PubMed
  179. Cho YK, et al. 2022. Nat Commun. 13:4084. PubMed
  180. Bao C, et al. 2021. Infect Immun. 89:. PubMed
  181. Dmitrieva‐Posocco O et al. 2019. Immunity. 50(1):166-180 . PubMed
  182. Tavazoie MF, et al. 2018. Cell. 172:825. PubMed
  183. Wang Q, et al. 2018. Nat Commun. 9:559. PubMed
  184. Reismann D, et al. 2017. Nat Commun.. 10.1038/s41467-017-01538-9. PubMed
  185. Wen Y, et al. 2020. Hypertension. 869:75. PubMed
  186. Tacconi C, et al. 2021. Cell Reports. 35(2):108993. PubMed
  187. Elahi S, et al. 2020. Stem Cell Res. 43:101710. PubMed
  188. Osaka M, et al. 2016. Sci Rep. 6:21391. PubMed
  189. Zhou H, et al. 2022. Oncoimmunology. 11:2057892. PubMed
  190. Harnett MM, et al. 2022. Front Immunol. 13:953053. PubMed
  191. Shiraki N, et al. 2022. Stem Cell Reports. 17:221. PubMed
  192. Zhang Y, et al. 2021. J Immunol Res. 2021:5599439. PubMed
  193. Reinfeld BI, et al. 2021. Nature. 593:282. PubMed
  194. Endoh M, et al. 2020. Cell Reports. 30(6):1823-1834. PubMed
  195. Lu X, et al. 2015. J Immunol. 194:2011. PubMed
  196. Miller S, et al. 2016. Acta Biochim Biophys Sin. 48: 334-341. PubMed
  197. Engler AE, et al. 2020. Cell Reports. 33(13):108553. PubMed
  198. Riedelberger M, et al. 2020. Bio Protoc. e3552:10. PubMed
  199. Cho K, et al. 2021. iScience. 24:103117. PubMed
  200. Zhu Y, et al. 2021. EMBO J. 40:e105320. PubMed
  201. Bakker W, et al. 2021. Int J Mol Sci. 22:. PubMed
  202. Li H, et al. 2021. Nat Commun. 12:7149. PubMed
  203. Shan C, et al. 2021. Front Immunol. 12:766401. PubMed
  204. Sobecki M, et al. 2021. Nat Commun. 12:4700. PubMed
  205. Nishida J, et al. 2022. STAR Protoc. 3:101306. PubMed
  206. Yamada KJ, et al. 2020. PLoS Pathog. 16:e1008354. PubMed
  207. Simões FC, et al. 2020. Nat Commun. 0.875. PubMed
  208. Ku AT et al. 2017. eLife. 6 pii: e23242. PubMed
  209. Lei J, et al. 2021. Theranostics. 4251:11. PubMed
  210. Alonso-Herranz L, et al. 2020. Elife. 9:00. PubMed
  211. Chen X, et al. 2016. PLoS One. 11:e0168861. PubMed
  212. Uto T, et al. 2016. Nat Commun. 7: 11273. PubMed
  213. Leon-Rico D, et al. 2015. Lab Anim. 49:132. PubMed
  214. Dong L, et al. 2022. Cells. 11:. PubMed
  215. Li Y, et al. 2022. Front Cardiovasc Med. 9:830781. PubMed
  216. Tang C, et al. 2021. Theranostics. 11:9791. PubMed
  217. Frost JN, et al. 2021. Med (N Y). 2:164. PubMed
  218. Gopinath A, et al. 2022. NPJ Parkinsons Dis. 8:72. PubMed
  219. Sun S, et al. 2021. Front Immunol. 12:777665. PubMed
  220. Jäger M, et al. 2018. Antioxid Redox Signal. 30. PubMed
  221. Nowlan B, et al. 2019. Haematologica. 105:71. PubMed
  222. Liu D, et al. 2020. Front Pharmacol. 11:204. PubMed
  223. Merlo LM, et al. 2020. Clin Pathol. 13:2632010X20951812. PubMed
  224. Quenum Zangbede FO, et al. 2018. J Neurosci. 38:6737. PubMed
  225. Ding X, et al. 2015. J Immunol. 194:4251. PubMed
  226. Wang H, et al. 2020. Nat Mater. 1.655555556. PubMed
  227. Takesue S, et al. 2020. Int J Oncol. 56:596. PubMed
  228. Wei Z, et al. 2021. Nat Commun. 0.805555556. PubMed
  229. Penkert RR, et al. 2020. Obesity (Silver Spring). 1631:28. PubMed
  230. Taddio MF, et al. 2021. Mol Imaging Biol. 23:196. PubMed
  231. Xu Q, et al. 2021. Theranostics. 11:1937. PubMed
  232. Liu P, et al. 2022. iScience. 25:103867. PubMed
  233. Ryan NM, et al. 2022. Front Immunol. 13:932742. PubMed
  234. Niemi JP, et al. 2020. Methods Mol Biol. 2143:207. PubMed
  235. Dionisio-Santos DA, et al. 2021. Front Neurosci. 15:758677. PubMed
  236. Chen RJ, et al. 2022. iScience. 25:105595. PubMed
  237. Zhuo Y, et al. 2018. Oncol Rep. 40:2147. PubMed
  238. Ponzetta A, et al. 2020. Cell. 178(2):346-360.e24.. PubMed
  239. Ibrahim ML, et al. 2018. Cell Rep. 25:3036. PubMed
  240. Lima-Junior D, et al. 2017. J Immunol. 10.4049/jimmunol.1700258. PubMed
  241. Dong R, et al. 2021. Frontiers in Immunology. 12:620238. PubMed
  242. Chen S, et al. 2020. Allergy Asthma Immunol Res. 0.922222222. PubMed
  243. Morikawa M, et al. 2016. PLoS One. 11:e0163607. PubMed
  244. Chen F, et al. 2016. J Immunol. 196: 4390 - 4399. PubMed
  245. Stevenson ER, et al. 2022. J Pharmacol Exp Ther. 382:356. PubMed
  246. Chen Y, et al. 2022. Life Sci. 306:120826. PubMed
  247. Ben-Yehuda H, et al. 2021. Mol Neurodegener. 16:39. PubMed
  248. Nechama M, et al. 2018. Nat Commun. 9:1603. PubMed
  249. Wang T et al. 2018. Immunity. 49(3):504-514 . PubMed
  250. Adachi Y, et al. 2019. Nat Commun. 10:3883. PubMed
  251. Ohgomori T et al. 2019. J Comp Neurol. 528(1):14-31 . PubMed
  252. Li S, et al. 2019. Front Neurol. 1.036805556. PubMed
  253. Ostapoff K, et al. 2013. Mol Cancer Ther. 12:1190. PubMed
  254. Macagno M, et al. 2014. J Immunol. 192:5434. PubMed
  255. Chou H, et al. 2015. Proc Natl Acad Sci U S A. 112:2175. PubMed
  256. Quan S, et al. 2015. J Immunol. 194:4175. PubMed
  257. Richardson ET, et al. 2015. PLoS One. 10: 1371. PubMed
  258. Yamamuro T, et al. 2020. Nat Commun. 3.340277778. PubMed
  259. Jiang L, et al. 2020. Cell. 183(5):1219-1233.e18. PubMed
  260. He S, et al. 2021. Front Pharmacol. 12:743837. PubMed
  261. Hua X, et al. 2021. Front Immunol. 12:706027. PubMed
  262. Feng L, et al. 2022. Signal Transduct Target Ther. 7:21. PubMed
  263. Zhang MS, et al. 2022. Nat Commun. 13:954. PubMed
  264. Zhang C, et al. 2021. J Immunother Cancer. 9:. PubMed
  265. Nasser H, et al. 2020. Cell Death Discov. 0.29375. PubMed
  266. Baumann D, et al. 2020. Nat Commun. 1.969444444. PubMed
  267. Kitamura K, et al. 2019. Int J Cardiol Heart Vasc. 23:100344. PubMed
  268. Namkoong H, et al. 2018. PLoS Pathog. 14:e1006955. PubMed
  269. Grayczyk JP et al. 2017. Cell host & microbe. 22(5):678-687 . PubMed
  270. Alter C et al. 2019. Am J Physiol Heart Circ Physiol. 317(1):H190-H200 . PubMed
  271. Spolski R et al. 2019. Elife. 8 pii: e45501. PubMed
  272. Tian D, et al. 2019. Nat Commun. 10:4246. PubMed
  273. Li K, et al. 2020. J Cell Mol Med. 24:13115. PubMed
  274. Damgaard RB et al. 2016. Cell. 166(5):1215-1230 . PubMed
  275. Roderick J, et al. 2014. Proc Natl Acad Sci U S A. 111:14436. PubMed
  276. Li Q, et al. 2022. Front Oncol. 12:841977. PubMed
  277. Rao L, et al. 2020. Nat Commun. 11:4909. PubMed
  278. Zhang GL, et al. 2020. Matrix Biol. 93:25. PubMed
  279. Chen Y, et al. 2022. Nat Commun. 13:4468. PubMed
  280. Huang T, et al. 2022. Nat Commun. 13:3489. PubMed
  281. Mihalik NE, et al. 2021. AAPS PharmSciTech. 22:191. PubMed
  282. Li Y, et al. 2022. STAR Protoc. 3:101364. PubMed
  283. Leary N, et al. 2022. J Extracell Vesicles. 11:e12197. PubMed
  284. Zhou H, et al. 2021. Cell Death Discov. 7:332. PubMed
  285. Golan K et al. 2018. Cell stem cell. 23(4):572-585 . PubMed
  286. Glodde N et al. 2017. Immunity. 47(4):789-802 . PubMed
  287. Fox D, et al. 2020. Nat Commun. 0.986111111. PubMed
  288. Deng M, et al. 2019. J Exp Med. 216:2838. PubMed
  289. Chan JY, et al. 2019. Diabetologia. 62:993. PubMed
  290. Erin N, et al. 2015. Brain Behav Immun. 48: 174-185. PubMed
  291. Zhang T, et al. 2020. JCI Insight. 5:00. PubMed
  292. Zhang D, et al. 2020. Signal Transduct Target Ther. 5:24. PubMed
  293. Matsumoto M, et al. 2021. Cell Host Microbe. 29(6):930-940.e4. PubMed
  294. Yang X, et al. 2021. Bioact Mater. 3150:6. PubMed
  295. Adzika GK, et al. 2021. Front Cell Dev Biol. 9:719351. PubMed
  296. Tang S, et al. 2022. Virol J. 19:32. PubMed
  297. Cui Y, et al. 2022. Front Oncol. 12:732860. PubMed
  298. Deliyannis G, et al. 2021. JCI Insight. 6:. PubMed
  299. Tähtinen S, et al. 2022. Nat Immunol. 23:532. PubMed
  300. Wagner AK, et al. 2022. iScience. 25:105137. PubMed
  301. Woods B, et al. 2019. Clin Cancer Res. 25:5901. PubMed
  302. Han P, et al. 2020. Sci Adv. 6:eaaz1580. PubMed
  303. Calvente CJ, et al. 2019. J Clin Invest. 130:4091. PubMed
  304. Burton OT, et al. 2018. Clin Exp Allergy. 48:288. PubMed
  305. Ortiz A, et al. 2019. Cancer Cell. 35:33:00. PubMed
  306. Uehara M, et al. 2019. Sci Rep. 9:6535. PubMed
  307. Liu SS, et al. 2021. Immunity. :. PubMed
  308. Zhou JH, et al. 2020. Onco Targets Ther. 7.278472222. PubMed
  309. Sitapara RA, et al. 2020. Mol Med. 26:63. PubMed
  310. Yu H, et al. 2015. PLoS One. 10: 0143001. PubMed
  311. Zhong B, et al. 2013. Sci Signal. 6:35. PubMed
  312. Wang Y, et al. 2022. Nat Commun. 13:1454. PubMed
  313. Zhang XL, et al. 2022. J Am Heart Assoc. 11:e023800. PubMed
  314. Wang X, et al. 2022. Elife. 11:. PubMed
  315. Adzika GK, et al. 2021. Front Cardiovasc Med. 8:719805. PubMed
  316. Chen X, et al. 2021. Cell Death Dis. 12:1123. PubMed
  317. Chen J, et al. 2021. Oncol Lett. 21:409. PubMed
  318. Bartley A, et al. 2018. Front Physiol. 9:1593. PubMed
  319. Geng S, et al. 2019. Sci Adv. 5:eaav2309. PubMed
  320. Arima Y et al. 2017. eLife. 6 pii: e25517. PubMed
  321. Krotova K, et al. 2019. Mol Ther Oncolytics. 15:166. PubMed
  322. Lai NY, et al. 2020. Cell. 180:33:00. PubMed
  323. Liu Z, et al. 2020. STAR Protoc. 1:100029. PubMed
  324. Hegde V, et al. 2015. J Immunol. 194:5211. PubMed
  325. Chen MB, et al. 2020. Cell Rep. 30:4418. PubMed
  326. Tran S, et al. 2020. Immunity. 53(3):627-640.e5. PubMed
  327. Katsuyama T, et al. 2021. Cell Reports. 36(1):109339. PubMed
  328. Goldberg EL, et al. 2021. Cell Metabolism. :. PubMed
  329. Luo ZW, et al. 2021. Int J Nanomedicine. 16:2949. PubMed
  330. Schäfer AL, et al. 2021. Front Immunol. 12:696810. PubMed
  331. Lee A, et al. 2022. Nat Commun. 13:549. PubMed
  332. Shin SH, et al. 2022. Clin Exp Otorhinolaryngol. . PubMed
  333. Palma A, et al. 2022. Front Cell Dev Biol. 10:841548. PubMed
  334. Jia J, et al. 2022. Nat Commun. 13:6804. PubMed
  335. Ribechini E, et al. 2017. Blood Adv. 0.699305556. PubMed
  336. Riopel M, et al. 2019. Mol Metab. 20:89. PubMed
  337. Moriyasu T, et al. 2018. PLoS Negl Trop Dis. 12:e0006197. PubMed
  338. Dai B, et al. 2021. Cell Reports Medicine. 2(8):100381. PubMed
  339. Trivedi S, et al. 2020. Elife. 9:00. PubMed
  340. Chng S, et al. 2016. Sci Rep. 6: 23820. PubMed
  341. Koronyo Y, et al. 2015. Brain. 138: 2399-2422. PubMed
  342. Zhao Y, et al. 2013. J Leukoc Biol. 94:1103. PubMed
  343. Xu Z, et al. 2022. Cell Death Dis. 13:502. PubMed
  344. Wang S, et al. 2022. Blood. 140:171. PubMed
  345. Song X, et al. 2022. Transl Oncol. 15:101306. PubMed
  346. Davis FM, et al. 2021. J Exp Med. 218:. PubMed
  347. Wu KKL, et al. 2021. Nat Commun. 12:6637. PubMed
  348. Amend A, et al. 2021. Int J Mol Sci. 22:. PubMed
  349. Xue Y, et al. 2020. Sci Rep. 10:22265. PubMed
RRID
AB_312788 (BioLegend Cat. No. 101205)
AB_312789 (BioLegend Cat. No. 101206)

Antigen Details

Structure
Integrin family, associates with integrin β2 (CD18), 170 kD
Distribution

Granulocytes, monocytes/macrophages, dendritic cells, NK cells, subsets of T and B cells

Function
Adhesion, chemotaxis
Ligand/Receptor
ICAM-1 (CD54), ICAM-2 (CD102), ICAM-4 (CD242), iC3b, fibrinogen
Cell Type
B cells, Dendritic cells, Granulocytes, Macrophages, Monocytes, Neutrophils, NK cells, T cells, Tregs
Biology Area
Cell Adhesion, Cell Biology, Costimulatory Molecules, Immunology, Innate Immunity, Neuroscience, Neuroscience Cell Markers
Molecular Family
Adhesion Molecules, CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Springer TA. 1994. Cell 76:301.
3. Coxon A, et al. 1996. Immunity 5:653.

Gene ID
16409 View all products for this Gene ID 3684 View all products for this Gene ID
UniProt
View information about CD11b on UniProt.org

Related FAQs

There are no FAQs for this product.

Other Formats

View All CD11b Reagents Request Custom Conjugation
Description Clone Applications
APC anti-mouse/human CD11b M1/70 FC
Biotin anti-mouse/human CD11b M1/70 FC
FITC anti-mouse/human CD11b M1/70 FC
PE anti-mouse/human CD11b M1/70 FC, IHC
PE/Cyanine5 anti-mouse/human CD11b M1/70 FC
Purified anti-mouse/human CD11b M1/70 FC, CyTOF®, IP, IHC-F, ICC
PE/Cyanine7 anti-mouse/human CD11b M1/70 FC
Alexa Fluor® 488 anti-mouse/human CD11b M1/70 FC, IHC-F, 3D IHC, SB
Alexa Fluor® 647 anti-mouse/human CD11b M1/70 FC, 3D IHC
Alexa Fluor® 700 anti-mouse/human CD11b M1/70 FC
Pacific Blue™ anti-mouse/human CD11b M1/70 FC
APC/Cyanine7 anti-mouse/human CD11b M1/70 FC
PerCP/Cyanine5.5 anti-mouse/human CD11b M1/70 FC
PerCP anti-mouse/human CD11b M1/70 FC
Brilliant Violet 421™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 570™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 605™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 650™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 711™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 785™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 510™ anti-mouse/human CD11b M1/70 FC, ICC
Ultra-LEAF™ Purified anti-mouse/human CD11b M1/70 FC, CyTOF®, IP, Block, Depletion, IHC-F, ICC
Purified anti-mouse/human CD11b (Maxpar® Ready) M1/70 FC, CyTOF®
Alexa Fluor® 594 anti-mouse/human CD11b M1/70 IHC-F, FC
PE/Dazzle™ 594 anti-mouse/human CD11b M1/70 FC
APC/Fire™ 750 anti-mouse/human CD11b M1/70 FC
TotalSeq™-A0014 anti-mouse/human CD11b M1/70 PG
Brilliant Violet 750™ anti-mouse/human CD11b M1/70 FC
TotalSeq™-B0014 anti-mouse/human CD11b M1/70 PG
TotalSeq™-C0014 anti-mouse/human CD11b M1/70 PG
Spark NIR™ 685 anti-mouse/human CD11b M1/70 FC
PE/Fire™ 640 anti-mouse/human CD11b M1/70 FC
Spark YG™ 593 anti-mouse/human CD11b M1/70 FC
Spark YG™ 570 anti-mouse/human CD11b M1/70 IHC-F
PE/Fire™ 810 anti-mouse/human CD11b M1/70 FC
APC/Fire™ 810 anti-mouse/human CD11b Antibody M1/70 FC
Spark Blue™ 550 anti-mouse/human CD11b M1/70 FC
Spark UV™ 387 anti-mouse/human CD11b M1/70 FC
Go To Top Version: 1    Revision Date: 11-30-2012

For research use only. Not for diagnostic use. Not for resale. BioLegend will not be held responsible for patent infringement or other violations that may occur with the use of our products.

 

*These products may be covered by one or more Limited Use Label Licenses (see the BioLegend Catalog or our website, www.biolegend.com/ordering#license). BioLegend products may not be transferred to third parties, resold, modified for resale, or used to manufacture commercial products, reverse engineer functionally similar materials, or to provide a service to third parties without written approval of BioLegend. By use of these products you accept the terms and conditions of all applicable Limited Use Label Licenses. Unless otherwise indicated, these products are for research use only and are not intended for human or animal diagnostic, therapeutic or commercial use.

 

BioLegend Inc., 8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

  • APC anti-mouse/human CD11b

  • Biotin anti-mouse/human CD11b

  • FITC anti-mouse/human CD11b

  • PE anti-mouse/human CD11b

  • PE/Cyanine5 anti-mouse/human CD11b

  • Purified anti-mouse/human CD11b

  • PE/Cyanine7 anti-mouse/human CD11b

  • Alexa Fluor® 488 anti-mouse/human CD11b

  • Alexa Fluor® 647 anti-mouse/human CD11b

  • Alexa Fluor® 700 anti-mouse/human CD11b

  • Pacific Blue™ anti-mouse/human CD11b

  • APC/Cyanine7 anti-mouse/human CD11b

  • PerCP/Cyanine5.5 anti-mouse/human CD11b

  • PerCP anti-mouse/human CD11b

  • Brilliant Violet 421™ anti-mouse/human CD11b

  • Brilliant Violet 570™ anti-mouse/human CD11b

  • Brilliant Violet 605™ anti-mouse/human CD11b

  • Brilliant Violet 650™ anti-mouse/human CD11b

  • Brilliant Violet 711™ anti-mouse/human CD11b

  • Brilliant Violet 785™ anti-mouse/human CD11b

  • Brilliant Violet 510™ anti-mouse/human CD11b

  • Ultra-LEAF™ Purified anti-mouse/human CD11b

  • Purified anti-mouse/human CD11b (Maxpar® Ready)

  • Alexa Fluor® 594 anti-mouse/human CD11b

  • PE/Dazzle™ 594 anti-mouse/human CD11b

  • APC/Fire™ 750 anti-mouse/human CD11b

  • TotalSeq™-A0014 anti-mouse/human CD11b

  • Brilliant Violet 750™ anti-mouse/human CD11b

  • TotalSeq™-B0014 anti-mouse/human CD11b

  • TotalSeq™-C0014 anti-mouse/human CD11b

  • Spark NIR™ 685 anti-mouse/human CD11b

  • PE/Fire™ 640 anti-mouse/human CD11b

  • Spark YG™ 593 anti-mouse/human CD11b

  • Spark YG™ 570 anti-mouse/human CD11b

  • PE/Fire™ 810 anti-mouse/human CD11b

  • APC/Fire™ 810 anti-mouse/human CD11b Antibody

  • Spark Blue™ 550 anti-mouse/human CD11b

  • Spark UV™ 387 anti-mouse/human CD11b

ProductsHere

Login / Register
Remember me
Forgot your password? Reset password?
Create an Account